Argenica Therapeutics (ASX: AGN) gears up for clinical trial of promising novel stroke treatment (w/ Liz Dallimore)

Small Caps - A podcast by Small Caps

Argenica Therapeutics (ASX: AGN) chief executive officer Dr Liz Dallimore joins Small Caps to discuss the company's upcoming phase 1...